Asian Bioethics Review, published by SPRINGER, is a premier journal indexed with ISSN 1793-8759 and E-ISSN 1793-9453, dedicated to advancing discourse in the interdisciplinary field of bioethics across Asia and beyond. Established in 2015, this esteemed publication has rapidly gained recognition, achieving a Q1 ranking in Philosophy and Q2 in key categories such as Health Policy and Issues, Ethics and Legal Aspects in 2023. With its robust Scopus rankings highlighting its significance across diverse domains—including a remarkable 98th percentile ranking in Philosophy—the journal serves as a vital platform for researchers, ethicists, and policymakers to explore pressing ethical issues and contribute to policy development in health and social sciences. Although not open access, the journal ensures a wide reach through institutional subscriptions, making it an essential resource for students and professionals committed to ethical practices in healthcare. Set in the dynamic backdrop of Singapore, "Asian Bioethics Review" continues to shape the conversation around bioethical practices in the Asian context and globally.

Acta Bioethica is a pivotal open access journal published by the Universidad de Chile's Centro Interdisciplinario de Estudios Bioética, dedicated to the multidisciplinary exploration of bioethical issues in health policy and social sciences. Since its inception in 2000, the journal has fostered dialogue among researchers, professionals, and students, addressing the complexities of ethical practices in diverse health contexts. With an impressive commitment to accessibility, Acta Bioethica has become a vital resource for those engaged in understanding the ethics of healthcare in Latin America and beyond. Although currently ranked in the lower quartiles of Scopus in both health policy and social sciences, the journal is steadily gaining recognition for its unique contributions to bioethics. The journal accepts contributions in both English and Spanish, ensuring a wider reach and impact in the academic community. Located in Santiago, Chile, and active from 2007 to 2024, Acta Bioethica continues to be an essential platform for advancing research and discussions in the ever-evolving field of bioethics.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

PERSPECTIVES IN BIOLOGY AND MEDICINE, published by the esteemed Johns Hopkins University Press, has been a cornerstone of interdisciplinary dialogue since its inception in 1957. With a rich history spanning over six decades, this journal delves into the multifaceted interactions between biology and medicine, offering insights that are vital for health policy, ethics, and the philosophy of science. Recognized for its impact, it holds a Q2 ranking in the History and Philosophy of Science category and Q3 rankings in several other relevant fields as of 2023. While not an open-access publication, it provides critical analyses and discussions that are indispensable for researchers, professionals, and students alike. With its committed editorial team, PERSPECTIVES IN BIOLOGY AND MEDICINE continues to foster scholarly engagement and is poised to shape the future discourse in the biosciences.

Ethik in der Medizin, published by Springer, is a distinguished journal focusing on the interdisciplinary aspects of ethics in medicine, healthcare policy, and philosophical inquiries related to these domains. With an ISSN of 0935-7335 and an E-ISSN of 1437-1618, this journal serves as a platform for innovative research and discussion from Germany and beyond. The journal boasts an impact in several prestigious categories including Q3 in Health Policy and Q2 in Philosophy as of 2023, reflecting its significant contribution to the discourse on ethical implications in health and medicine. Although not currently Open Access, Ethik in der Medizin provides valuable insights for researchers, professionals, and students interested in the complexities of health ethics and policies, positioning itself as an essential resource in academia. The journal is undergoing important developments, as it converges from 2001 with a publishing timeline extending to 2024, ensuring continued relevance in a rapidly evolving field.

HEC Forum, an esteemed journal published by Springer, is dedicated to advancing the field of health policy and ethics, bridging critical gaps between healthcare practices and legal frameworks. With the ISSN 0956-2737 and the E-ISSN 1572-8498, this journal has been a pivotal platform since its inception in 1989, collaborating with scholars and practitioners up to the year 2024. Recognized within the Q3 quartile of several categories—including Health Policy and Issues, Ethics and Legal Aspects—HEC Forum holds a significant position in scholarly circles, showcasing rigorous research and discussions relevant to today’s health care challenges. The journal's Scopus rankings highlight its impact, positioned favorably in the realms of Nursing and Health Policy. Although it does not offer open access, HEC Forum remains a critical resource for researchers, professionals, and students seeking to deepen their understanding of health ethics and policy implications in a rapidly evolving landscape.

BIOETHICS is a leading academic journal published by Wiley, dedicated to exploring the multifaceted issues at the intersection of healthcare, philosophy, and policy. With an ISSN of 0269-9702 and an E-ISSN of 1467-8519, it has established itself as a critical platform for scholarly discourse since its inception in 1987. The journal holds impressive rankings, featuring in the Q1 category in both Health (social science) and Philosophy, alongside a Q2 rating in Health Policy for 2023. This positions BIOETHICS in the top echelons of its fields, ranking 35th out of 806 in Philosophy and garnering high percentiles across relevant disciplines. By fostering a deeper understanding of ethical implications in medical and social contexts, BIOETHICS serves as an essential resource for researchers, professionals, and students committed to addressing contemporary challenges in health and policy. The journal is accessible through institutional subscriptions and offers an engaging platform for the dissemination of significant research findings and theoretical advancements, paving the way for future exploration in bioethical inquiry.

Cuadernos de Bioetica, published by the ASOC ESPANOLA BIOETICA & ETICA MEDICA, is a prominent academic journal dedicated to exploring significant philosophical, ethical, and legal dimensions within the field of bioethics. With an ISSN of 1132-1989 and an E-ISSN of 2386-3773, this journal serves as a vital platform for researchers, professionals, and students in medicine and related disciplines. Since its inception in 2008, it has consistently provided critical analyses and discussions reflecting the evolving landscape of healthcare ethics, contributing notably to the discourse surrounding ethical practices in medicine. Despite its current Q4 ranking in the miscellaneous medicine category, Cuadernos de Bioetica is committed to enhancing its impact and relevance, making it an essential resource for those seeking to navigate the complex ethical challenges in contemporary medical practice. The journal’s reach is underscored by its commitment to fostering open dialogue among diverse stakeholders in the field, encouraging a broad spectrum of contributions to advance knowledge in bioethics.

The Journal of Bioethical Inquiry, published by Springer, is a prominent academic journal in the fields of bioethics, health policy, and social sciences. Established in 2004 and running through 2024, it is recognized for providing a critical platform for the exploration of ethical issues arising in the contexts of healthcare and policy making. With an ISSN of 1176-7529 and an E-ISSN of 1872-4353, this esteemed journal holds a Q2 quartile ranking in both Health Policy and Health (Social Science) categories, indicating its significant impact and contributions to the field. It boasts impressive Scopus rankings, with a standing of #70 out of 371 in Social Sciences _ Health (Social Science) and #68 out of 310 in Medicine _ Health Policy, representing its relevance and authority in these domains. Although it does not currently offer open access options, the Journal of Bioethical Inquiry remains a vital resource for researchers, practitioners, and students eager to engage with the complexities of bioethical challenges and to advance the discourse on health policies.

Canadian Journal of Bioethics-Revue Canadienne de Bioethique, published by the Universite de Montreal, is a premier open-access journal dedicated to advancing the multidisciplinary field of bioethics since 2012. Emphasizing the complexities of ethical practices in health policy, it serves as a vital resource for researchers, professionals, and students engaged in health and philosophy. With its E-ISSN 2561-4665, the journal's content is freely accessible, fostering knowledge dissemination and academic collaboration. Although categorized in Q4 among Health Policy and Health (social science) in 2023, it holds a respectable Q2 status in Philosophy, reflecting its strong theoretical contributions. Covering a wide scope from 2018 to 2024, the journal encourages robust discourse on pressing ethical issues facing contemporary healthcare systems. For those seeking to connect with the evolving narratives in bioethics, this journal is indispensable.